Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
spinnovation-analytical.com

See what CB Insights has to offer

Founded Year

2004

Stage

Acquired | Acquired

About Spinnovation Holding

Spinnovation consists of Spinnovation Analytical and Spinnovation Biologics. The former is specialized in performing contract research and supplying contract analysis services to support the Life Science industries while the latter focuses on providing services for profiling and characterizing bioprocesses, biologics and biosimilars. One specific technology developed by Spinnovation Biologics is Spedia-NMRTM, i.e. spent media analyses which gives customers detailed insight in concentration profiles of their cell culture media enabling them to optimize their cell lines and bioprocesses in a very cost efficient manner.

Spinnovation Holding Headquarter Location

Molenweg 50 Pivot Park (RK1223)

Oss, 5349 AC,

Netherlands

+31-24-240-3400

Latest Spinnovation Holding News

Sinensis Life Sciences Acquires Spinnovation

Oct 14, 2014

Sinensis Life Sciences Acquires Spinnovation 04:10 EDT 14 Oct 2014 | Lab Bulletin Home » News » Sinensis Life Sciences Acquires Spinnovation Sinensis Life Sciences B.V. has acquired Spinnovation Holding B.V. a contract research organisation specialised in the application of nuclear magnetic resonance (NMR) techniques in the pharmaceutical and biotechnological market. Financial terms of the transaction were not disclosed. The addition of Spinnovation expands and strengthens Sinensis’ chemical R&D group as in addition to NMR Spinnovation offers mass spectrometry (MS) and inductively coupled plasma (ICP) spectroscopy analyses to its customers. Dr Ruud Santing, CEO of Sinensis, commented: “We are excited to add Spinnovation’s analytical equipment and many years of expertise to our existing... Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.